BEGIN:VCALENDAR
VERSION:2.0
PRODID:www.eu-parc.eu
BEGIN:VEVENT
UID:6a3e829379e86
DTSTART;VALUE=DATE:20260922
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20260923
SUMMARY:Population Pharmacokinetic Modelling (PopPK) and Physiologically Ba
sed Pharmacokinetic Modelling (PBPK)
CLASS:PUBLIC
DESCRIPTION:The Courses on Population Pharmacokinetic Modelling (PopPK) and
Physiologically Based Pharmacokinetic Modelling (PBPK) will take place fr
om 22 to 25 September 2026 at the University of Helsinki\, Finland. Partic
ipants may attend either the two-day PopPK or PBPK course\, or both. The c
ourses provide a comprehensive introduction to pharmacokinetic modelling t
hrough expert lectures and hands-on exercises using MonolixSuite and PK-Si
m software. Topics include population pharmacokinetics and pharmacodynamic
s\, physiologically based pharmacokinetic modelling\, drug-drug interactio
ns\, pharmacogenetics\, in vitro–in vivo extrapolation (IVIVE)\, and app
lications in patient care and chemical risk assessment. The practical sess
ions will enable participants to apply modelling approaches using real-wor
ld examples and specialised software. \;Target audienceThese courses a
re particularly relevant for postgraduate students and postdoctoral resear
chers in pharmacy\, drug discovery and development\, clinical and biomedic
al research\, and toxicology. They are also suitable for professionals int
erested in developing practical skills in PopPK and PBPK modelling and the
ir applications in research\, healthcare\, and regulatory science.
X-ALT-DESC;FMTTYPE=text/html:The Courses on P
opulation Pharmacokinetic Modelling (PopPK) and Physiologically Based Phar
macokinetic Modelling (PBPK) will take place from 22 to 25 September 2026
at the University of Helsinki\, Finland. Participants may attend either th
e two-day PopPK or PBPK course\, or both. The courses provide a comprehens
ive introduction to pharmacokinetic modelling through expert lectures and
hands-on exercises using MonolixSuite and PK-Sim software. Topics include
population pharmacokinetics and pharmacodynamics\, physiologically based p
harmacokinetic modelling\, drug-drug interactions\, pharmacogenetics\, in
vitro–in vivo extrapolation (IVIVE)\, and applications in patient care a
nd chemical risk assessment. The practical sessions will enable participan
ts to apply modelling approaches using real-world examples and specialised
software.
\;
Target audience
These c
ourses are particularly relevant for postgraduate students and postdoctora
l researchers in pharmacy\, drug discovery and development\, clinical and
biomedical research\, and toxicology. They are also suitable for professio
nals interested in developing practical skills in PopPK and PBPK modelling
and their applications in research\, healthcare\, and regulatory science.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260626T134555Z
END:VEVENT
BEGIN:VEVENT
UID:6a3e829379ed9
DTSTART;VALUE=DATE:20260923
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20260924
SUMMARY:Population Pharmacokinetic Modelling (PopPK) and Physiologically Ba
sed Pharmacokinetic Modelling (PBPK)
CLASS:PUBLIC
DESCRIPTION:The Courses on Population Pharmacokinetic Modelling (PopPK) and
Physiologically Based Pharmacokinetic Modelling (PBPK) will take place fr
om 22 to 25 September 2026 at the University of Helsinki\, Finland. Partic
ipants may attend either the two-day PopPK or PBPK course\, or both. The c
ourses provide a comprehensive introduction to pharmacokinetic modelling t
hrough expert lectures and hands-on exercises using MonolixSuite and PK-Si
m software. Topics include population pharmacokinetics and pharmacodynamic
s\, physiologically based pharmacokinetic modelling\, drug-drug interactio
ns\, pharmacogenetics\, in vitro–in vivo extrapolation (IVIVE)\, and app
lications in patient care and chemical risk assessment. The practical sess
ions will enable participants to apply modelling approaches using real-wor
ld examples and specialised software. \;Target audienceThese courses a
re particularly relevant for postgraduate students and postdoctoral resear
chers in pharmacy\, drug discovery and development\, clinical and biomedic
al research\, and toxicology. They are also suitable for professionals int
erested in developing practical skills in PopPK and PBPK modelling and the
ir applications in research\, healthcare\, and regulatory science.
X-ALT-DESC;FMTTYPE=text/html:The Courses on P
opulation Pharmacokinetic Modelling (PopPK) and Physiologically Based Phar
macokinetic Modelling (PBPK) will take place from 22 to 25 September 2026
at the University of Helsinki\, Finland. Participants may attend either th
e two-day PopPK or PBPK course\, or both. The courses provide a comprehens
ive introduction to pharmacokinetic modelling through expert lectures and
hands-on exercises using MonolixSuite and PK-Sim software. Topics include
population pharmacokinetics and pharmacodynamics\, physiologically based p
harmacokinetic modelling\, drug-drug interactions\, pharmacogenetics\, in
vitro–in vivo extrapolation (IVIVE)\, and applications in patient care a
nd chemical risk assessment. The practical sessions will enable participan
ts to apply modelling approaches using real-world examples and specialised
software.
\;
Target audience
These c
ourses are particularly relevant for postgraduate students and postdoctora
l researchers in pharmacy\, drug discovery and development\, clinical and
biomedical research\, and toxicology. They are also suitable for professio
nals interested in developing practical skills in PopPK and PBPK modelling
and their applications in research\, healthcare\, and regulatory science.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260626T134555Z
END:VEVENT
BEGIN:VEVENT
UID:6a3e829379eea
DTSTART;VALUE=DATE:20260924
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20260925
SUMMARY:Population Pharmacokinetic Modelling (PopPK) and Physiologically Ba
sed Pharmacokinetic Modelling (PBPK)
CLASS:PUBLIC
DESCRIPTION:The Courses on Population Pharmacokinetic Modelling (PopPK) and
Physiologically Based Pharmacokinetic Modelling (PBPK) will take place fr
om 22 to 25 September 2026 at the University of Helsinki\, Finland. Partic
ipants may attend either the two-day PopPK or PBPK course\, or both. The c
ourses provide a comprehensive introduction to pharmacokinetic modelling t
hrough expert lectures and hands-on exercises using MonolixSuite and PK-Si
m software. Topics include population pharmacokinetics and pharmacodynamic
s\, physiologically based pharmacokinetic modelling\, drug-drug interactio
ns\, pharmacogenetics\, in vitro–in vivo extrapolation (IVIVE)\, and app
lications in patient care and chemical risk assessment. The practical sess
ions will enable participants to apply modelling approaches using real-wor
ld examples and specialised software. \;Target audienceThese courses a
re particularly relevant for postgraduate students and postdoctoral resear
chers in pharmacy\, drug discovery and development\, clinical and biomedic
al research\, and toxicology. They are also suitable for professionals int
erested in developing practical skills in PopPK and PBPK modelling and the
ir applications in research\, healthcare\, and regulatory science.
X-ALT-DESC;FMTTYPE=text/html:The Courses on P
opulation Pharmacokinetic Modelling (PopPK) and Physiologically Based Phar
macokinetic Modelling (PBPK) will take place from 22 to 25 September 2026
at the University of Helsinki\, Finland. Participants may attend either th
e two-day PopPK or PBPK course\, or both. The courses provide a comprehens
ive introduction to pharmacokinetic modelling through expert lectures and
hands-on exercises using MonolixSuite and PK-Sim software. Topics include
population pharmacokinetics and pharmacodynamics\, physiologically based p
harmacokinetic modelling\, drug-drug interactions\, pharmacogenetics\, in
vitro–in vivo extrapolation (IVIVE)\, and applications in patient care a
nd chemical risk assessment. The practical sessions will enable participan
ts to apply modelling approaches using real-world examples and specialised
software.
\;
Target audience
These c
ourses are particularly relevant for postgraduate students and postdoctora
l researchers in pharmacy\, drug discovery and development\, clinical and
biomedical research\, and toxicology. They are also suitable for professio
nals interested in developing practical skills in PopPK and PBPK modelling
and their applications in research\, healthcare\, and regulatory science.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260626T134555Z
END:VEVENT
BEGIN:VEVENT
UID:6a3e829379ef8
DTSTART;VALUE=DATE:20260925
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20260926
SUMMARY:Population Pharmacokinetic Modelling (PopPK) and Physiologically Ba
sed Pharmacokinetic Modelling (PBPK)
CLASS:PUBLIC
DESCRIPTION:The Courses on Population Pharmacokinetic Modelling (PopPK) and
Physiologically Based Pharmacokinetic Modelling (PBPK) will take place fr
om 22 to 25 September 2026 at the University of Helsinki\, Finland. Partic
ipants may attend either the two-day PopPK or PBPK course\, or both. The c
ourses provide a comprehensive introduction to pharmacokinetic modelling t
hrough expert lectures and hands-on exercises using MonolixSuite and PK-Si
m software. Topics include population pharmacokinetics and pharmacodynamic
s\, physiologically based pharmacokinetic modelling\, drug-drug interactio
ns\, pharmacogenetics\, in vitro–in vivo extrapolation (IVIVE)\, and app
lications in patient care and chemical risk assessment. The practical sess
ions will enable participants to apply modelling approaches using real-wor
ld examples and specialised software. \;Target audienceThese courses a
re particularly relevant for postgraduate students and postdoctoral resear
chers in pharmacy\, drug discovery and development\, clinical and biomedic
al research\, and toxicology. They are also suitable for professionals int
erested in developing practical skills in PopPK and PBPK modelling and the
ir applications in research\, healthcare\, and regulatory science.
X-ALT-DESC;FMTTYPE=text/html:The Courses on P
opulation Pharmacokinetic Modelling (PopPK) and Physiologically Based Phar
macokinetic Modelling (PBPK) will take place from 22 to 25 September 2026
at the University of Helsinki\, Finland. Participants may attend either th
e two-day PopPK or PBPK course\, or both. The courses provide a comprehens
ive introduction to pharmacokinetic modelling through expert lectures and
hands-on exercises using MonolixSuite and PK-Sim software. Topics include
population pharmacokinetics and pharmacodynamics\, physiologically based p
harmacokinetic modelling\, drug-drug interactions\, pharmacogenetics\, in
vitro–in vivo extrapolation (IVIVE)\, and applications in patient care a
nd chemical risk assessment. The practical sessions will enable participan
ts to apply modelling approaches using real-world examples and specialised
software.
\;
Target audience
These c
ourses are particularly relevant for postgraduate students and postdoctora
l researchers in pharmacy\, drug discovery and development\, clinical and
biomedical research\, and toxicology. They are also suitable for professio
nals interested in developing practical skills in PopPK and PBPK modelling
and their applications in research\, healthcare\, and regulatory science.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260626T134555Z
END:VEVENT
END:VCALENDAR